Výsledky vyhledávání

Akademický článek

Exposure-Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM.

Autor: Lindauer A; Calvagone SAS, Chazay d'Azergues, France., Snoeck E; Luccio bv, Rozenlaan 26, Retie, 2470, Belgium., Laveille C; Calvagone SAS, Chazay d'Azergues, France., Ayani I; Laboratorios Farmaceuticos ROVI, S.A., Alfonso Gómez, Madrid, Spain., de Monasterioguren LOD; Laboratorios Farmaceuticos ROVI, S.A., Alfonso Gómez, Madrid, Spain., Almendros M; Laboratorios Farmaceuticos ROVI, S.A., Alfonso Gómez, Madrid, Spain., Martínez-González J; Laboratorios Farmaceuticos ROVI, S.A., Alfonso Gómez, Madrid, Spain., Anta L; Laboratorios Farmaceuticos ROVI, S.A., Alfonso Gómez, Madrid, Spain., Gutierro I; Laboratorios Farmaceuticos ROVI, S.A., Alfonso Gómez, Madrid, Spain.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Zobrazit plný text záznamu

Akademický článek

Development of a population pharmacokinetic model for the novel long-acting injectable antipsychotic risperidone ISM®.

Autor: Laveille C; Calvagone SAS, Liergues, France., Snoeck E; Luccio bv, Retie, Belgium., Ochoa Díaz de Monasterioguren L; Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain., Martínez-González J; Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain., Llaudó J; Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain., Anta L; Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain., Gutierro I; Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Sep; Vol. 90 (9), pp. 2256-2270. Date of Electronic Publication: 2024 Jun 12.

Zobrazit plný text záznamu

Akademický článek

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study

Autor: Walling DP, Hassman HA, Anta L, Ochoa L, Ayani I, Martínez J, Gutierro I

Publikováno v: Drug Design, Development and Therapy, Vol Volume 15, Pp 4371-4382 (2021)

David P Walling,1 Howard A Hassman,2 Lourdes Anta,3 Lourdes Ochoa,4 Ignacio Ayani,3 Javier Martínez,3 Ibon Gutierro4 1Collaborative Neuroscience Network, LLC Garden Grove, Garden Grove, CA, USA; 2Hassman Research Institute, Berlin, NJ, USA; 3Medical

Externí odkaz: https://doaj.org/article/a256d4300d484f2c90cfa6b6c8041253

Zobrazit plný text záznamu

Akademický článek

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]

Autor: Walling DP, Hassman HA, Anta L, Ochoa L, Ayani I, Martínez J, Gutierro I

Publikováno v: Drug Design, Development and Therapy, Vol Volume 16, Pp 1791-1792 (2022)

Walling DP, Hassman HA, Anta L, et al. Drug Des Devel Ther. 2021;15:4371–4382. Page 4378, Table 2, PK Parameter column, the text “Cave (ng/nL)” should read “Cave (ng/mL)”. Page 4379, Table 3, PK Parameter column, the text “Cave (ng/nL)”

Externí odkaz: https://doaj.org/article/72234dfaaa7a41919e747cfd6aa4e887

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání